A selective adenosine A1 receptor agonist has been shown to significantly reduce extracellular levels of glutamate in VA/VL thalamic nuclei in rats, as well as significantly reduce the amplitude of harmaline-induced tremor (Kosmowska et al., 2020). Here, ADORA1 is linked to Tremor.